Clinical Trial Update: A Study of BL-B01D1+PD-1/PD-L1 Monoclonal Antibody in Patients With Advanced Biliary Tract Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating BL-B01D1 in combination with a PD-1/PD-L1 monoclonal antibody for advanced biliary tract cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Cholangiocarcinoma

Drugs mentioned

• BL-B01D1
• PD-1/PD-L1 monoclonal antibody

Snippet

Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. | Conditions: Advanced Biliary Tract Cancer | Phase 2 | Status: RECRUITING